 Cardiovascular effects volatile anesthesia rabbits influence chronic heart failure enalaprilat treatment Circulatory responses anesthesia rabbits biventricular cardiomyopathy doxorubicin Adriamycin mg/kg IV wk controls saline injections preliminary operations flow probes aorta renal artery abdominal aorta group wk treatment development congestive heart failure CHF decreases mean arterial pressure cardiac output CO increase heart rate controls anesthetic agent dose-related decreases mean arterial pressure increases heart rate significant changes Renal blood flow similar degree MAC halothane decrease MAC isoflurane decrease blood flow halothane CHF attenuation heart rate response Halothane CO advanced stages CHF changes renal blood flow hindlimb blood flow anesthetic CHF group similar controls vary week treatment Administration angiotensin-converting enzyme inhibitor enalaprilat IV CO renal blood flow effects halothane wk treatment CHF group combination halothane enalaprilat severe circulatory depression